Safety of Intravenous Autologous Bone Marrow-Derived Mesenchymal Cell Transplantation in 5 Patients With Reduced Left Ventricular Ejection Fraction-Reference-Cited by-同舟云学术

Safety of Intravenous Autologous Bone Marrow-Derived Mesenchymal Cell Transplantation in 5 Patients With Reduced Left Ventricular Ejection Fraction

Published:2021-09-10 Issue:9 Volume:3 Page:550-554
ISSN:2434-0790
Container-title:Circulation Reports
language:en
Short-container-title:Circ Rep

Author:

Sato Yukihito¹,Kuragaichi Takashi¹,Saga Shunsuke¹,Nakayama Hiroyuki¹,Obata Tomoe²,Watanabe Mitsumasa³,Fujikura Kie⁴,Watanabe Masatoki⁴,Hata Ken-ichiro⁴,Ohgushi Hajime⁵

Affiliation:

1. Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center

2. Department of Clinical Laboratory, Hyogo Prefectural Amagasaki General Medical Center

3. Department of Hematology, Hyogo Prefectural Amagasaki General Medical Center

4. Japan Tissue Engineering Co., Ltd. (J-TEC)

5. Department of Orthopedic Surgery, Ookuma Hospital

Publisher

Japanese Circulation Society

Subject

Marketing,Organizational Behavior and Human Resource Management,Strategy and Management,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.jstage.jst.go.jp/article/circrep/3/9/3_CR-21-0091/_pdf

Reference18 articles.

1. 1. Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): A systematic review and meta-analysis of clinical trials. PLoS One 2012; 7: e47559.

2. 2. Fan M, Huang Y, Chen Z, Xia Y, Chen A, Lu D, et al. Efficacy of mesenchymal stem cell therapy in systolic heart failure: A systematic review and meta-analysis. Stem Cell Res Ther 2019; 10: 150.

3. 3. Shen T, Xia L, Dong W, Wang J, Su F, Niu S, et al. Systematic review and meta-analysis: Safety and efficacy of mesenchymal stem cells therapy for heart failure. Curr Stem Cell Res Ther 2021; 16: 354–365.

4. 4. Miyagawa S, Domae K, Yoshikawa Y, Fukushima S, Nakamura T, Saito A, et al. Phase I clinical trial of autologous stem cell-sheet transplantation therapy for treating cardiomyopathy. J Am Heart Assoc 2017; 6: e003918.

5. 5. Noda T, Nishigaki K, Minatoguchi S. Safety and efficacy of human Muse cell-based product for acute myocardial infarction in a first-in-human trial. Circ J 2020; 84: 1189–1192.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesenchymal Stem Cell Therapy for a Better Prognosis of Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Cureus;2023-08-06